Therapeutic effects of beta-thujaplicin eardrops on canine Malassezia-related otitis externa

J Vet Med Sci. 2006 Apr;68(4):373-4. doi: 10.1292/jvms.68.373.

Abstract

An eardrop solution of beta-thujaplicin was examined for therapeutic effects on canine Malassezia-related otitis externa. Half to one ml of beta-thujaplicin solution of 100 microg/ml including DMSO 2% was injected everyday into both external ear canals of 31 cases for test-of-cure agreement. Fifteen score phases were established from the symptoms and cerumen smear biopsy findings, and score changes were recorded at least once a week. The means of the second and the third inspection day scores decreased significantly more than the previous value of each. In addition, the numbers of yeast-like organisms clearly decreased. These results suggest that beta-thujaplicin eardrops are effective for Malassezia-related otitis externa in dogs.

Publication types

  • Clinical Trial

MeSH terms

  • Animals
  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / therapeutic use
  • Dermatomycoses / drug therapy
  • Dermatomycoses / microbiology
  • Dermatomycoses / veterinary*
  • Dog Diseases / drug therapy*
  • Dog Diseases / microbiology*
  • Dogs
  • Malassezia / drug effects
  • Malassezia / physiology
  • Monoterpenes / administration & dosage*
  • Monoterpenes / therapeutic use*
  • Otitis Externa / drug therapy
  • Otitis Externa / microbiology
  • Otitis Externa / veterinary*
  • Time Factors
  • Tropolone / administration & dosage
  • Tropolone / analogs & derivatives*
  • Tropolone / therapeutic use

Substances

  • Anti-Infective Agents
  • Monoterpenes
  • Tropolone
  • beta-thujaplicin